+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novartis AG - logo

Novartis is a global healthcare company based in Basel, Switzerland. They have created a patient-centered portfolio consisting of a wide range of products and treatments to address unmet medical needs. Novartis focuses its business on three leading divisions: pharmaceuticals, eye care and generics. They are expanding their presence in the emerging markets of Asia, Africa and Latin America, where there is fast-growing demand for access to high-quality medicines and healthcare.

Dyslipidemia Drugs Market - Global Strategic Business Report - Product Thumbnail Image

Dyslipidemia Drugs Market - Global Strategic Business Report

  • Report
  • September 2026
  • 268 Pages
  • Global
From
Atherosclerosis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Atherosclerosis Therapeutics - Global Strategic Business Report

  • Report
  • September 2026
  • 181 Pages
  • Global
From
Endothelial Dysfunction Market - Global Strategic Business Report - Product Thumbnail Image

Endothelial Dysfunction Market - Global Strategic Business Report

  • Report
  • September 2026
  • 370 Pages
  • Global
From
Cardiac Arrhythmias Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Cardiac Arrhythmias Therapeutics - Global Strategic Business Report

  • Report
  • September 2026
  • 183 Pages
  • Global
From
Pericarditis Drugs - Global Strategic Business Report - Product Thumbnail Image

Pericarditis Drugs - Global Strategic Business Report

  • Report
  • September 2026
  • 289 Pages
  • Global
From
Orthostatic Hypotension Drugs - Global Strategic Business Report - Product Thumbnail Image

Orthostatic Hypotension Drugs - Global Strategic Business Report

  • Report
  • September 2026
  • 286 Pages
  • Global
From
Hemorrhagic Stroke Drugs - Global Strategic Business Report - Product Thumbnail Image

Hemorrhagic Stroke Drugs - Global Strategic Business Report

  • Report
  • September 2026
  • 287 Pages
  • Global
From
Atherosclerosis Drugs - Global Strategic Business Report - Product Thumbnail Image

Atherosclerosis Drugs - Global Strategic Business Report

  • Report
  • September 2026
  • 389 Pages
  • Global
From
Anticoagulant Reversal Drugs - Global Strategic Business Report - Product Thumbnail Image

Anticoagulant Reversal Drugs - Global Strategic Business Report

  • Report
  • September 2026
  • 140 Pages
  • Global
From
Lisinopril - Global Strategic Business Report - Product Thumbnail Image

Lisinopril - Global Strategic Business Report

  • Report
  • September 2026
  • 476 Pages
  • Global
From
Losartan Market - Global Strategic Business Report - Product Thumbnail Image

Losartan Market - Global Strategic Business Report

  • Report
  • September 2026
  • 384 Pages
  • Global
From
From
Cardiotonic Agents Market - Global Strategic Business Report - Product Thumbnail Image

Cardiotonic Agents Market - Global Strategic Business Report

  • Report
  • September 2026
  • 568 Pages
  • Global
From
From
Pulmonary Embolism Market Report 2026 - Product Thumbnail Image

Pulmonary Embolism Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Black Lung Disease Market Report 2026 - Product Thumbnail Image

Black Lung Disease Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Preeclampsia Drugs Market Report 2026 - Product Thumbnail Image

Preeclampsia Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Cyclic Heavy Menstrual Bleeding Market Report 2026 - Product Thumbnail Image

Cyclic Heavy Menstrual Bleeding Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Growth Factors Market - Global Forecast 2026-2032 - Product Thumbnail Image

Growth Factors Market - Global Forecast 2026-2032

  • Report
  • August 2026
  • 185 Pages
  • Global
From
Loading Indicator